EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Cancer Prevention Research

ISSN 1940-6207 · American Association for Cancer Research (AACR)

Latest articles

  1. Contextualizing web-based decision support for endocrine therapy for breast cancer risk reduction: Usability and context insights in a cluster randomized trial

    Julia D. Caci, Alissa Michel, Peter Zeiger, Anna Vaynrub, Cynthia Law, Vicky Ro, Christina Hijya, Garnet L. Anderson, Kathryn B. Arnold, Sam Dzingle, Sandhya Pruthi, Ana Sandoval-Leon, Rachel Shirley, Maria T. Grosse Perdekamp, Sarah V. Colonna, Stacy Krisher, Tari A. King, Lisa D. Yee, Tarah J. Ballinger, Christa Braun-Inglis, Debra A. Mangino, Kari B. Wisinski, Claudia A. DeYoung, Masey Ross, Justin Floyd, Andrea Kaster, Lindi H. VanderWalde, Thomas J. Saphner, Corrine Zarwan, Shelly Lo, Cathy L. Graham, Alison K. Conlin, Kathleen Y. Butler, Doreen M. Agnese, Cheryl L. Jernigan, Dawn L. Hershman, Marian L. Neuhouser, Jason A. Zell, Banu K. Arun, Rita Kukafka

    Published: 2026-11-18DOI: 10.1158/1940-6207.capr-26-0210

  2. Phase 1b breast cancer prevention clinical trial of 9cUAB30 administered prior to surgical resection

    Helen Krontiras, Lee G. Wilke, Katina DeShong, Kimaya Chaubal, Jianqing Zhang, Paul R. Hutson, Heather Green, Thomas C. Havighurst, KyungMann Kim, Richard J. Chappell, Lisa Barroilhet, Stephanie M. McGregor, Karla Esbona, Sasha E. Stanton, Jane Hui, Seema A. Khan, Eddy S. Yang, Edward R. Sauter, Brandy M. Heckman-Stoddard, Eileen Dimond, Margaret House, Howard H. Bailey

    Published: 2026-11-10DOI: 10.1158/1940-6207.capr-26-0007

Volumes

2026 · 892025 · 852024 · 692023 · 852022 · 1122021 · 1192020 · 1842019 · 962018 · 852017 · 902016 · 1142015 · 2722014 · 1382013 · 3572012 · 4132011 · 4862010 · 7462009 · 1582008 · 396

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.